The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2022

Filed:

Jul. 13, 2021
Applicant:

Photon Systems, Inc., Covina, CA (US);

Inventors:

Rohit Bhartia, Altadena, CA (US);

Michael R. Reid, Newport Beach, CA (US);

William F. Hug, Altadena, CA (US);

Ray D. Reid, Glendora, CA (US);

Assignee:

Photon Systems, Inc., Covina, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 21/64 (2006.01); G01N 21/33 (2006.01); G01N 33/569 (2006.01); G01N 21/3577 (2014.01); G01N 21/359 (2014.01); G01N 21/65 (2006.01); G01N 21/17 (2006.01);
U.S. Cl.
CPC ...
G01N 21/6486 (2013.01); G01N 21/33 (2013.01); G01N 21/359 (2013.01); G01N 21/3577 (2013.01); G01N 21/6456 (2013.01); G01N 21/658 (2013.01); G01N 33/56983 (2013.01); G01N 2021/1736 (2013.01); G01N 2021/6421 (2013.01); G01N 2021/6423 (2013.01); G01N 2021/656 (2013.01); G01N 2201/0221 (2013.01); G01N 2201/067 (2013.01); G01N 2201/129 (2013.01);
Abstract

Methods, apparatus, and systems provide improved identification of selected biohazard and/or biohazard signatures from complex in vivo or in vitro samples and include deep UV native fluorescence spectroscopic analysis for multiple locations of a sample wherein classification results for individual locations are combined and spatially correlated to provide a positive or negative conclusion of biohazard signature presence (e.g., for signatures for viruses, bacteria, and diseases including SARS-CoV-2 and its variants and COVID-19 and its variants). Improvements include one or more of reduced sample processing time (minutes to fractions of a minute), reduced sampling cost (dollars to fractions of a dollar), high conclusion reliability (rivaling real time RT-PCR). Some embodiments may incorporate a stage or scanning mirror system to provide movement of a sample relative to an excitation exposure location. Some embodiments may incorporate Raman or phosphorescence spectroscopic analysis as well as imaging systems.


Find Patent Forward Citations

Loading…